rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    GRCE
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Opaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock
      Nov 6Investing.comGRCE
      Opaleye management buys $158,600 Grace Therapeutics stock
      Oct 26Investing.comGRCE
      Opaleye Management buys $8,001 of Grace Therapeutics common stock
      Oct 21Investing.comGRCE
      Opaleye management, 10% owner, buys $136,177 Grace Therapeutics (GRCE)
      Oct 17Investing.comGRCE
      Opaleye management director buys $29,682 of Grace Therapeutics stock
      Oct 13Investing.comGRCE
      Opaleye management, a 10% owner, buys $123,819 of Grace Therapeutics stock
      Oct 6Investing.comGRCE
      Grace Therapeutics director Opaleye Management buys $31,686 in stock
      Sep 24Investing.comGRCE
      Grace Therapeutics Shareholders Back Board, Pay and Auditor

      Detailed price information for Grace Therapeutics Inc (GRCE-Q) from The Globe and Mail including charting and trades.

      Sep 19The Globe and MailGRCE
      Grace Therapeutics CEO Kohli acquires $214,000 in common stock
      Sep 10Investing.comGRCE
      Grace Therapeutics Files for Resale of Up to 4.8 Million Shares

      Grace Therapeutics (GRCE) filed a registration statement Monday with the US Securities and Exchange

      Aug 24Yahoo FinanceGRCE

      This is the newest page. Registered accounts read further back.